Zepbound (tirzepatide) and Wegovy (semaglutide) are designed for adults who are overweight or have obesity, and both have proven benefits, but they also have important differences that are important to understand
Healthcare professionals should consult applicable FDA guidance, professional society recommendations, and institutional policies when managing individual patients.
These efforts aim to improve the comparability and reliability of findings through the adoption of standardized data formats [245, 647]
And today when they should, it's hard to announce all those belief systems and step outside of it
In large-scale cardiovascular outcome trials, enhanced GLP-1 signaling has reduced the risk of atherosclerotic ischemic events, potentially because GLP-1 retards the growth and increases the stability of atherosclerotic plaques